Keybanc cut the price target for Baxter International Inc. (NYSE: BAX) from $53 to $51. Keybanc analyst Matthew Mishan maintained an Overweight rating. Baxter International shares rose 1.2% to $47.58 in pre-market trading.
Baxter International Inc (NYSE: BAX) posted Q2 revenue of $3.71 billion, which missed the consensus of $3.79 billion, up 3% Y/Y on a reported basis and up
As Baxter International Inc (NYSE: BAX) prepares to release its second-quarter 2023 financial results on July 27, Stifel analyst writes it is an opportune time for investors to consider owning BAX shares.